Overall Winner: Butterfly Network·85/ 100

Butterfly Network vs SigTuple

In-depth comparison — valuation, funding, investors, founders & more

Winner
B
Butterfly Network

🇺🇸 United States · John Martin

PublicAI HealthcareEst. 2011

Valuation

$1.5B

Total Funding

$700M

85
Awaira Score85/100

500-1000 employees

Full Butterfly Network Profile →
S
SigTuple

🇮🇳 India · Rohit Kumar Pandey

Series BAI HealthcareEst. 2015

Valuation

N/A

Total Funding

$20M

60
Awaira Score60/100

100-500 employees

Full SigTuple Profile →
🔬

Analyst Summary

Generated from real data · No AI hallucinations

Both Butterfly Network and SigTuple compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Butterfly Network produces the Butterfly iQ, a handheld ultrasound device powered by a proprietary semiconductor chip that replaces traditional piezoelectric transducer arrays with a single silicon chip capable of whole-body imaging. SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists.

Butterfly Network carries a known valuation of $1.5B, while SigTuple's valuation has not been publicly disclosed. On the funding side, Butterfly Network has raised $700M in total — $680M more than SigTuple's $20M.

Butterfly Network has 4 years more market experience, having been founded in 2011 compared to SigTuple's 2015 founding. In terms of growth stage, Butterfly Network is at Public while SigTuple is at Series B — a meaningful difference for investors evaluating risk and upside.

Butterfly Network operates out of 🇺🇸 United States while SigTuple is based in 🇮🇳 India, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, Butterfly Network leads with a score of 85, reflecting stronger overall fundamentals across valuation, funding, and growth signals.

Metrics Comparison

MetricButterfly NetworkSigTuple
💰Valuation
$1.5B
N/A
📈Total Funding
$700MWINS
$20M
📅Founded
2011
2015WINS
🚀Stage
Public
Series B
👥Employees
500-1000
100-500
🌍Country
United States
India
🏷️Category
AI Healthcare
AI Healthcare
Awaira Score
85WINS
60

Key Differences

📈

Funding gap: Butterfly Network has raised $680M more ($700M vs $20M)

📅

Market experience: Butterfly Network has 4 years more (founded 2011 vs 2015)

🚀

Growth stage: Butterfly Network is at Public vs SigTuple at Series B

👥

Team size: Butterfly Network has 500-1000 employees vs SigTuple's 100-500

🌍

Market base: 🇺🇸 Butterfly Network (United States) vs 🇮🇳 SigTuple (India)

⚔️

Direct competitors: Both operate in the AI Healthcare market segment

Awaira Score: Butterfly Network scores 85/100 vs SigTuple's 60/100

Which Should You Choose?

Use these signals to make the right call

B

Choose Butterfly Network if…

Top Pick
  • Higher Awaira Score — 85/100 vs 60/100
  • More established by valuation ($1.5B)
  • Stronger investor backing — raised $700M
  • More market experience — founded in 2011
  • United States-based for regional compliance or proximity
  • Butterfly Network produces the Butterfly iQ, a handheld ultrasound device powered by a proprietary semiconductor chip that replaces traditional piezoelectric transducer arrays with a single silicon chip capable of whole-body imaging
S

Choose SigTuple if…

  • India-based for regional compliance or proximity
  • SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists

Users Also Compare

FAQ — Butterfly Network vs SigTuple

Is Butterfly Network bigger than SigTuple?
Butterfly Network has a disclosed valuation of $1.5B, while SigTuple's valuation is not publicly available, making a direct size comparison difficult. Butterfly Network employs 500-1000 people.
Which company raised more funding — Butterfly Network or SigTuple?
Butterfly Network has raised more in total funding at $700M, compared to SigTuple's $20M — a gap of $680M.
Which company has a higher Awaira Score?
Butterfly Network holds the higher Awaira Score at 85/100, compared to SigTuple's 60/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 25-point gap that reflects meaningful differences in scale or traction.
Who founded Butterfly Network vs SigTuple?
Butterfly Network was founded by John Martin in 2011. SigTuple was founded by Rohit Kumar Pandey in 2015. Visit each company's profile on Awaira for a full founder biography.
What does Butterfly Network do vs SigTuple?
Butterfly Network: Butterfly Network produces the Butterfly iQ, a handheld ultrasound device powered by a proprietary semiconductor chip that replaces traditional piezoelectric transducer arrays with a single silicon chip capable of whole-body imaging. The AI software layer provides real-time image interpretation guidance, enabling clinicians with limited ultrasound training to perform diagnostic scans at the bedside.\n\nThe company is publicly traded on the NYSE under the ticker BFLY and raised over 700 million USD prior to and through its public listing. Butterfly has deployed devices across hospitals, emergency rooms, and point-of-care settings in over 50 countries, with particular penetration in resource-limited healthcare settings where traditional ultrasound equipment is prohibitively expensive or unavailable.\n\nPortable AI-assisted diagnostic imaging represents a structural shift in how and where medical imaging is performed. Butterfly Network has created a defensible position through its proprietary chip architecture, which competitors cannot easily replicate, and through its growing library of AI-assisted clinical guidance tools. The transition from hospital-based imaging to point-of-care diagnostics powered by AI guidance is a multi-decade trend that positions Butterfly at the center of a fundamental change in diagnostic medicine. SigTuple: SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists. The company's AI-Minth platform uses robotic sample preparation, high-resolution imaging, and deep learning analysis to deliver diagnostic-grade results.\n\nThe company raised approximately $20M in Series B funding and has deployed its automated microscopy systems at diagnostic labs, hospitals, and blood banks across India, processing millions of diagnostic samples. SigTuple has received regulatory approvals for its diagnostic AI products and has established partnerships with major diagnostic laboratory chains.\n\nIndia faces a severe shortage of qualified pathologists relative to population, creating an acute need for AI-assisted diagnostic automation. SigTuple's approach of combining hardware, robotics, and AI in an integrated system addresses the complete diagnostic workflow rather than just the software layer, creating higher deployment barriers but also higher switching costs and stronger network effects from accumulated diagnostic data.
Which company was founded first?
Butterfly Network was founded first in 2011, giving it 4 years of additional market experience. SigTuple was founded later in 2015. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.
Which company has more employees?
Butterfly Network has approximately 500-1000 employees, while SigTuple has approximately 100-500. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.
Are Butterfly Network and SigTuple competitors?
Yes, Butterfly Network and SigTuple are direct competitors — both operate in the AI Healthcare space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.